Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Lemtrada 12mg Infusion 1.2ml
Manufacturer/Marketed By : SANOFI INDIA LTD
$6189.44 $5570.50
Lemtrada 12mg Infusion 1.2ml is an immunosuppressive and anti-inflammatory medicine, classified as a monoclonal antibody, containing the active ingredient Alemtuzumab. It is primarily used to treat relapsing forms of multiple...
ALEMTUZUMAB
Active Pharmaceutical Ingredient
Lemtrada 12mg Infusion 1.2ml
$6,189.44
$5,570.50
Lemtrada 12mg Infusion 1.2ml is an immunosuppressive and anti-inflammatory medicine, classified as a monoclonal antibody, containing the active ingredient Alemtuzumab. It is primarily used to treat relapsing forms of multiple sclerosis (MS) in adults and, in some cases, to manage certain types of leukaemia (such as chronic lymphocytic leukaemia, CLL) or for immune system suppression before transplant procedures. While Lemtrada 12mg Infusion 1.2ml does not cure multiple sclerosis or leukaemia, it helps to slow the progression of the disease, reduce relapse frequency, and manage immune-related damage. This medication works by targeting and destroying immune cells that are thought to attack healthy tissues, thereby rebalancing the immune response. This medicine is administered under medical supervision as an intravenous infusion. Due to its strong immunosuppressive effects, it is typically given in treatment cycles, and patients are closely monitored before, during, and after each injection.
Active Pharmaceutical Ingredient
Uses
• Relapsing-Remitting Multiple Sclerosis (RRMS)
• Chronic Lymphocytic Leukaemia (CLL)
• Pre-transplant Conditioning (off-label use)
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Headache
• Fever or chills
• Nausea and vomiting
• Rash or itching
• Tiredness or weakness
• Back pain or joint pain
• Difficulty sleeping
• Mouth or throat pain
• Cough or shortness of breath
• Low white blood cell counts (may increase infection risk)
Common Side Effects
• Severe infections (e.g., pneumonia, urinary tract infections, viral reactivation)
• Autoimmune reactions (e.g., thyroid disorders, kidney problems)
• Infusion-related reactions (chest pain, drop in blood pressure, breathing difficulty)
• Liver problems (yellowing of skin or eyes, dark urine)
• Bleeding or bruising easily (due to low platelets)
• Neurological issues (confusion, vision changes, weakness in limbs)
• Risk of certain cancers (rare but possible with long-term use)
How To Use
Lemtrada 12mg Infusion 1.2ml is given through an intravenous (IV) infusion by a healthcare professional, not taken by mouth. It is administered in treatment cycles as decided by your doctor. Regular monitoring is needed during and after treatment. Do not miss or delay doses without medical advice, and follow your doctor’s instructions closely.
Safety Advice
• Breast Feeding: It is not known if Lemtrada 12mg Infusion 1.2ml passes into breast milk. To be safe, avoid breastfeeding during treatment and for a period after the last dose, as advised by your doctor.
• Alcohol: Avoid alcohol during treatment with Lemtrada 12mg Infusion 1.2ml, it may increase the risk of liver side effects and worsen fatigue or dizziness.
• Liver: Inform your doctor if you have liver problems such as hepatitis B or C. Lemtrada 12mg Infusion 1.2ml may worsen liver function, and regular liver tests may be needed.
• Lungs: Tell your doctor if you have any lung problems before starting Lemtrada 12mg Infusion 1.2ml. This medicine can weaken your immune system and make it easier to get lung infections. If you get a cough, breathing trouble, or chest pain during treatment, talk to your doctor right away.
• Driving: This medicine may cause dizziness, fatigue, or confusion in some patients. Avoid driving or operating heavy machinery until you know how Lemtrada 12mg Infusion 1.2ml affects you.
• Pregnancy: Avoid using Lemtrada 12mg Infusion 1.2ml during pregnancy unless clearly prescribed by your doctor. It may harm the unborn baby. Use effective contraception during treatment and for at least 4 months after the last dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.